Suppr超能文献

羧基末端蛋白酶调节猪布鲁氏菌在培养中的形态以及在巨噬细胞和小鼠体内的存活。

Carboxyl-terminal protease regulates Brucella suis morphology in culture and persistence in macrophages and mice.

作者信息

Bandara Aloka B, Sriranganathan Nammalwar, Schurig Gerhardt G, Boyle Stephen M

机构信息

Center for Molecular Medicine and Infectious Diseases, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, 1410 Prices Fork Rd., Blacksburg, VA 24061-0342, USA.

出版信息

J Bacteriol. 2005 Aug;187(16):5767-75. doi: 10.1128/JB.187.16.5767-5775.2005.

Abstract

The putative carboxyl-terminal processing protease (CtpA) of Brucella suis 1330 is a member of a novel family of endoproteases involved in the maturation of proteins destined for the cell envelope. The B. suis CtpA protein shared up to 77% homology with CtpA proteins of other bacteria. A CtpA-deficient Brucella strain (1330DeltactpA), generated by allelic exchange, produced smaller colonies on enriched agar plates and exhibited a 50% decrease in growth rate in enriched liquid medium and no growth in salt-free enriched medium compared to the wild-type strain 1330 or the ctpA-complemented strain 1330DeltactpA[pBBctpA]. Electron microscopy revealed that in contrast to the native coccobacillus shape of wild-type strain 1330, strain 1330DeltactpA possessed a spherical shape, an increased cell diameter, and cell membranes partially dissociated from the cell envelope. In the J774 mouse macrophage cell line, 24 h after infection, the CFU of the strain 1330DeltactpA declined by approximately 3 log(10) CFU relative to wild-type strain 1330. Nine weeks after intraperitoneal inoculation of BALB/c mice, strain 1330DeltactpA had cleared from spleens but strain 1330 was still present. These observations suggest that the CtpA activity is necessary for the intracellular survival of B. suis. Relative to the saline-injected mice, strain 1330DeltactpA-vaccinated mice exhibited 4 to 5 log(10) CFU of protection against challenge with virulent B. abortus strain 2308 or B. suis strain 1330 but no protection against B. melitensis strain 16 M. This is the first report correlating a CtpA deficiency with cell morphology and attenuation of B. suis.

摘要

猪布鲁氏菌1330的假定羧基末端加工蛋白酶(CtpA)是一个新的内切蛋白酶家族的成员,该家族参与定位于细胞膜的蛋白质的成熟过程。猪布鲁氏菌CtpA蛋白与其他细菌的CtpA蛋白具有高达77%的同源性。通过等位基因交换产生的CtpA缺陷型布鲁氏菌菌株(1330DeltactpA),在富集琼脂平板上形成的菌落较小,在富集液体培养基中的生长速率比野生型菌株1330或ctpA互补菌株1330DeltactpA[pBBctpA]降低了50%,在无盐富集培养基中不生长。电子显微镜显示,与野生型菌株1330的天然球杆菌形状不同,菌株1330DeltactpA呈球形,细胞直径增大,细胞膜部分与细胞壁分离。在J774小鼠巨噬细胞系中,感染24小时后,相对于野生型菌株1330,菌株1330DeltactpA的CFU下降了约3 log(10) CFU。对BALB/c小鼠进行腹腔接种9周后,菌株1330DeltactpA已从脾脏中清除,但菌株1330仍存在。这些观察结果表明,CtpA活性对猪布鲁氏菌的细胞内存活是必需的。相对于注射生理盐水的小鼠,接种菌株1330DeltactpA的小鼠对强毒流产布鲁氏菌菌株2308或猪布鲁氏菌菌株1330的攻击表现出4至5 log(10) CFU的保护作用,但对马尔他布鲁氏菌菌株16M没有保护作用。这是首次将CtpA缺陷与猪布鲁氏菌的细胞形态和减毒相关联的报告。

相似文献

10
Delta-pgm, a new live-attenuated vaccine against Brucella suis.德尔塔-pgm,一种新型的猪布鲁氏菌减毒活疫苗。
Vaccine. 2016 Mar 18;34(13):1524-1530. doi: 10.1016/j.vaccine.2016.02.025. Epub 2016 Feb 17.

引用本文的文献

7
Proteomics of Brucella.布鲁氏菌的蛋白质组学
Proteomes. 2020 Apr 22;8(2):8. doi: 10.3390/proteomes8020008.

本文引用的文献

1
Improved prediction of signal peptides: SignalP 3.0.信号肽预测的改进:SignalP 3.0
J Mol Biol. 2004 Jul 16;340(4):783-95. doi: 10.1016/j.jmb.2004.05.028.
6
Brucellosis vaccines: past, present and future.布鲁氏菌病疫苗:过去、现在与未来
Vet Microbiol. 2002 Dec 20;90(1-4):479-96. doi: 10.1016/s0378-1135(02)00255-9.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验